ProCE Banner Activity

Key HIV Studies Influencing My Practice Following AIDS 2022—Dr. David Wohl

Multimedia

Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral therapies, long-acting therapies, cure, and COVID-19 in PWH.

Released: August 19, 2022

Expiration: August 18, 2023

No longer available for credit.

Share

Faculty

David A. Wohl

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS 2021

ProCE Banner

Faculty Disclosure

Primary Author

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

David A. Wohl, MD, has disclosed that he has received funds for research support from Gilead Sciences and Merck and consulting fees from Gilead Sciences, Janssen, Merck, and ViiV.